0.6518
Schlusskurs vom Vortag:
$0.639
Offen:
$0.6363
24-Stunden-Volumen:
197.83K
Relative Volume:
0.65
Marktkapitalisierung:
$82.33M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-70.78M
KGV:
-1.1639
EPS:
-0.56
Netto-Cashflow:
$-61.27M
1W Leistung:
-5.12%
1M Leistung:
-12.04%
6M Leistung:
-46.13%
1J Leistung:
-73.72%
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Firmenname
Nautilus Biotechnology Inc
Sektor
Branche
Telefon
206-333-2001
Adresse
2701 EASTLAKE AVE EAST, SEATTLE
Vergleichen Sie NAUT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
NAUT
Nautilus Biotechnology Inc
|
0.6518 | 84.95M | 0 | -70.78M | -61.27M | -0.56 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-05 | Herabstufung | Goldman | Neutral → Sell |
2024-06-27 | Eingeleitet | Guggenheim | Buy |
2024-06-03 | Fortgesetzt | Jefferies | Hold |
2022-01-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
2021-11-02 | Eingeleitet | Cowen | Outperform |
2021-08-04 | Eingeleitet | Goldman | Neutral |
2021-07-13 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Nautilus Biotechnology Inc Aktie (NAUT) Neueste Nachrichten
What machine learning models say about Nautilus Biotechnology Inc.Trade Volume Summary & Verified Chart Pattern Trade Signals - Newser
Trend analysis for Nautilus Biotechnology Inc. this weekJuly 2025 Drop Watch & Reliable Price Breakout Alerts - Newser
Is Nautilus Biotechnology Inc. a candidate for recovery playQuarterly Portfolio Report & Smart Investment Allocation Insights - Newser
Is Nautilus Biotechnology Inc. showing signs of accumulationQuarterly Profit Review & Safe Investment Capital Preservation Plans - Newser
Why Nautilus Biotechnology Inc. is moving todayWeekly Risk Report & Community Consensus Picks - Newser
Applying Wyckoff theory to Nautilus Biotechnology Inc. stockLong Setup & Weekly Setup with ROI Potential - Newser
What the charts say about Nautilus Biotechnology Inc. todayFed Meeting & Real-Time Buy Signal Alerts - Newser
Intraday pattern recognizer results for Nautilus Biotechnology Inc.Weekly Risk Report & Reliable Intraday Trade Alerts - Newser
Nautilus Biotechnology Inc. stock momentum explainedJuly 2025 Outlook & Free Technical Pattern Based Buy Signals - Newser
How does Nautilus Biotechnology Inc. compare to its peersJuly 2025 Price Swings & High Accuracy Trade Alerts - خودرو بانک
Published on: 2025-09-02 01:17:17 - Newser
Is Nautilus Biotechnology Inc. stock a buy or sell2025 Macro Impact & Real-Time Chart Breakout Alerts - khodrobank.com
How to track smart money flows in Nautilus Biotechnology Inc.Weekly Trade Report & Technical Confirmation Trade Alerts - Newser
Profit Recap: Is Nautilus Biotechnology Inc. stock risky to hold nowShort Setup & Capital Protection Trade Alerts - khodrobank.com
Nautilus Biotechnology Inc. Stock Recovery Path — Analyst Breakdown getLinesFromResByArray error: size == 0 - thegnnews.com
Is Nautilus Biotechnology Inc. stock risky to hold nowJuly 2025 Recap & Stepwise Trade Signal Implementation - kpenews.com
What high frequency data says about Nautilus Biotechnology Inc.July 2025 Outlook & Daily Volume Surge Signals - Newser
Using flow based indicators on Nautilus Biotechnology Inc.Portfolio Performance Summary & Community Driven Trade Alerts - Newser
Nautilus Biotechnology Inc. stock prediction for this week2025 Earnings Surprises & Verified High Yield Trade Plans - Newser
Can trapped investors hope for a rebound in Nautilus Biotechnology Inc.2025 Pullback Review & AI Driven Stock Reports - Newser
Is it too late to sell Nautilus Biotechnology Inc.Quarterly Profit Review & Real-Time Stock Entry Alerts - Newser
Published on: 2025-08-31 12:20:51 - Newser
Price Consolidation Hints at Upcoming Move in Nautilus Biotechnology Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Technical analysis overview for Nautilus Biotechnology Inc. stockTrade Performance Summary & Fast Exit and Entry Strategy Plans - Newser
Heatmap analysis for Nautilus Biotechnology Inc. and competitorsMarket Risk Analysis & Weekly High Potential Alerts - Newser
Building trade automation scripts for Nautilus Biotechnology Inc.Portfolio Profit Report & Real-Time Volume Trigger Notifications - Newser
Understanding Nautilus Biotechnology Inc.’s price movementMarket Activity Summary & Daily Momentum Trading Reports - Newser
Combining price and volume data for Nautilus Biotechnology Inc.Trade Analysis Report & Reliable Entry Point Trade Alerts - Newser
Is Nautilus Biotechnology Inc. stock entering bullish territoryWeekly Trading Summary & Long-Term Investment Growth Plans - Newser
How to integrate Nautilus Biotechnology Inc. into portfolio analysis toolsPortfolio Performance Summary & Weekly High Potential Stock Alerts - Newser
Published on: 2025-08-30 04:51:02 - Newser
Quantitative breakdown of Nautilus Biotechnology Inc. recent moveGap Up & Free Fast Entry Momentum Trade Alerts - Newser
Key resistance and support levels for Nautilus Biotechnology Inc.July 2025 Technicals & Verified Momentum Stock Watchlist - Newser
Finanzdaten der Nautilus Biotechnology Inc-Aktie (NAUT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Nautilus Biotechnology Inc-Aktie (NAUT) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Mallick Parag | Chief Scientist |
May 08 '25 |
Buy |
0.73 |
12,000 |
8,788 |
20,491,892 |
Mallick Parag | Chief Scientist |
May 12 '25 |
Buy |
0.73 |
1,500 |
1,098 |
20,493,392 |
Patel Sujal M | CEO, President, and Secretary |
Mar 19 '25 |
Buy |
0.99 |
53,300 |
53,028 |
10,117,788 |
Patel Sujal M | CEO, President, and Secretary |
Mar 20 '25 |
Buy |
1.00 |
23,933 |
23,890 |
10,141,721 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):